In fact, our results demonstrate that addition of Ad5/3-E2F-d24-vIL2 virus bolstered NK cell therapy killing effects in a set of OvCa human samples in ex vivo co-cultures regardless of tumor diagnosis or stage. This evidence concerns the gene EZR and neoplasm.